Relapsed multiple myeloma (otherwise known as recurrent myeloma) is the name given to a returning multiple myeloma cancer after treatment has been completed and/or a period of remission has been experienced. There is no cure for multiple myeloma and so a relapse is a possibility for many patients diagnosed with multiple myeloma cancer.
If you experience relapsed multiple myeloma, you should speak with your doctor right away.
In addition, you should also seek a second opinion from a doctor who has experience in treating multiple myeloma. Most doctors will advise you to see more than one doctor before you decide to move forward with any treatment course, be that for multiple myeloma or relapsed multiple myeloma.
There are many new multiple myeloma drugs being developed, and so patients will have a number of treatment options available for them when experiencing relapsed multiple myeloma.
One such treatment is or Carfilzomib. is a selective inhibitor which acts as an anti-cancer drug treatment for multiple myeloma patients. has shown promising results when treating relapsed, as well as refractory, multiple myeloma.
Another treatment often prescribed for relapsed multiple myeloma is or . is a proteasome inhibitor and was, in fact, the first proteasome inhibitor to be approved by the U.S. Food and Drug Administration (FDA). is used both in the treatment of relapsed multiple myeloma and in the treatment of mantle cell lymphoma. The proteasome inhibitor has been shown to improve response rates after initial multiple myeloma therapies as well. The drug was originally created in 1995.
Many treatments used for multiple myeloma can also be used in the case of relapsed multiple myeloma.
Patients are encouraged to consult their physician for more information on all multiple myeloma treatments to find the one that’s right for them in the case of relapsed multiple myeloma.
Featured image: Shidlovski via DepositPhotos